Resmed (RMD) Return on Invested Capital (2010 - 2026)

Resmed's Return on Invested Capital history runs 17 years deep, the most recent figure standing at 0.02% for Q1 2026.

• Quarterly Return on Invested Capital fell 32.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (down 32.0% YoY) and the FY2025 annual result came in at 1.42%, up 35.0% from the prior year.
• Return on Invested Capital was 0.02% for Q1 2026 at Resmed, down from 0.04% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.36% in Q2 2025 and bottomed at 0.0% in Q1 2022.
• A 5-year average of 0.17% and a median of 0.23% in 2023 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2023 — Return on Invested Capital grew 23 bps — and 2026, when it plunged 32 bps.
• Resmed's Return on Invested Capital stood at 0.02% in 2022, then soared by 925 bps to 0.23% in 2023, then soared by 37 bps to 0.32% in 2024, then plunged by 89 bps to 0.04% in 2025, then plunged by 37 bps to 0.02% in 2026.
• Business Quant data shows RMD's Return on Invested Capital at 0.02% in Q1 2026, 0.04% in Q4 2025, and 0.09% in Q3 2025.